Lab
Kaiser Foundation Health Plan of Colorado
Kaiser Foundation Health Plan of Colorado was paid $19.77M by Medicaid between Jan 2018 and Dec 2024, across 180 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 11% of everything it billed.
33Billing provider infoKAISER FOUNDATION HEALTH PLAN OF COLORADO
DENVER, CO 80239
DENVER, CO 80239
33aNPI1518071067assigned 08/19/2006
33bProvider typeClinical Medical Laboratory
28Total paid$19.77M
24GClaims1,424,396
24DCodes billed180
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Colorado
Rank by total paid#4 of 91
Median peer was paid$53K
This provider vs. median372×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RAMSEIER, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 186,089 | $3.09M | |
| 2019 | 131,575 | $2.27M | |
| 2020 | 140,808 | $1.98M | |
| 2021 | 221,220 | $3.12M | |
| 2022 | 232,931 | $3.09M | |
| 2023 | 273,545 | $3.24M | |
| 2024incomplete | 238,228 | $2.97M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 52,541 | 48,234 | $2.22M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.9% | 40,588 | 37,258 | $1.35M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.8% | 40,557 | 37,233 | $1.35M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.7% | 22,438 | 15,493 | $1.13M |
| 80061 | Lipid panel | 4.6% | 77,906 | 74,975 | $913K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.4% | 59,043 | 56,215 | $863K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 119,968 | 105,906 | $750K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.7% | 88,515 | 85,448 | $725K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.0% | 24,549 | 23,650 | $593K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.4% | 15,643 | 14,965 | $480K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.3% | 24,035 | 22,401 | $457K |
| 87481 | 2.1% | 24,705 | 19,533 | $409K |
168 more codes
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.1% | 20,687 | $408K |
| 80050 | General health panel | 1.7% | 10,463 | $345K |
| 82728 | 1.7% | 27,671 | $339K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.7% | 19,197 | $333K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.6% | 14,314 | $315K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 44,115 | $285K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 7,893 | $281K |
| 82607 | 1.3% | 20,845 | $261K | |
| 86003 | 1.2% | 7,311 | $243K | |
| 80053 | Comprehensive metabolic panel | 1.2% | 30,469 | $233K |
| 86803 | 1.1% | 17,849 | $215K | |
| 87088 | 1.1% | 29,377 | $211K | |
| 87650 | 1.0% | 7,774 | $205K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 11,969 | $195K |
| 80076 | <1% | 25,010 | $171K | |
| 87340 | <1% | 18,870 | $166K | |
| 83516 | <1% | 6,424 | $142K | |
| 83970 | <1% | 4,994 | $137K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,735 | $132K |
| 87511 | <1% | 5,258 | $129K | |
| 86704 | <1% | 12,404 | $126K | |
| 83550 | <1% | 16,527 | $124K | |
| 82565 | <1% | 30,383 | $120K | |
| 84439 | <1% | 14,039 | $120K | |
| 83880 | <1% | 4,609 | $113K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,321 | $112K |
| 82274 | <1% | 10,637 | $105K | |
| 84460 | <1% | 20,240 | $94K | |
| 82570 | <1% | 23,859 | $94K | |
| 83540 | <1% | 16,648 | $93K | |
| 84403 | <1% | 3,928 | $88K | |
| 84153 | <1% | 5,944 | $87K | |
| 86140 | <1% | 18,309 | $86K | |
| 82043 | <1% | 18,145 | $79K | |
| 86592 | <1% | 21,622 | $79K | |
| 88342 | <1% | 1,927 | $73K | |
| 85610 | <1% | 24,160 | $69K | |
| 83001 | <1% | 3,858 | $66K | |
| 82784 | <1% | 6,137 | $66K | |
| 88304 | <1% | 2,977 | $65K | |
| 84146 | <1% | 3,521 | $64K | |
| 82670 | <1% | 2,559 | $62K | |
| 86480 | <1% | 1,270 | $62K | |
| 87529 | <1% | 983 | $60K | |
| 84481 | <1% | 3,880 | $56K | |
| 86762 | <1% | 4,812 | $56K | |
| 83690 | <1% | 8,618 | $51K | |
| 80069 | <1% | 8,141 | $47K | |
| 86160 | <1% | 2,273 | $42K | |
| 84132 | <1% | 11,254 | $42K | |
| 84702 | <1% | 3,390 | $42K | |
| 82746 | <1% | 3,364 | $41K | |
| 87536 | <1% | 624 | $38K | |
| 88312 | <1% | 1,529 | $35K | |
| 86677 | <1% | 2,284 | $35K | |
| 86850 | <1% | 5,729 | $35K | |
| 84450 | <1% | 7,614 | $33K | |
| 82950 | <1% | 6,514 | $32K | |
| 83735 | <1% | 6,783 | $32K | |
| 86038 | <1% | 2,820 | $31K | |
| 87186 | <1% | 2,766 | $29K | |
| 87081 | <1% | 4,553 | $29K | |
| 81001 | <1% | 12,205 | $28K | |
| 87517 | <1% | 935 | $28K | |
| 85060 | <1% | 1,878 | $27K | |
| 88307 | <1% | 374 | $27K | |
| 87522 | Neg quan hep c or qual rna | <1% | 591 | $26K |
| 83002 | <1% | 1,495 | $26K | |
| 87046 | <1% | 2,020 | $25K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 363 | $25K |
| 81003 | <1% | 12,070 | $24K | |
| 84484 | <1% | 2,876 | $24K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 327 | $23K |
| 87329 | <1% | 2,187 | $23K | |
| 82627 | <1% | 1,099 | $23K | |
| 88141 | <1% | 1,661 | $23K | |
| 87427 | <1% | 2,018 | $23K | |
| 87070 | <1% | 2,692 | $21K | |
| 86200 | <1% | 1,890 | $20K | |
| 84295 | <1% | 4,952 | $18K | |
| 84550 | <1% | 4,858 | $18K | |
| 83721 | <1% | 2,788 | $18K | |
| 87045 | <1% | 2,016 | $18K | |
| 82550 | <1% | 3,281 | $17K | |
| 84156 | <1% | 5,963 | $17K | |
| 86706 | <1% | 1,856 | $17K | |
| 86769 | <1% | 539 | $17K | |
| 84100 | <1% | 6,144 | $16K | |
| 82105 | <1% | 1,126 | $15K | |
| 86225 | <1% | 1,321 | $14K | |
| 80074 | <1% | 352 | $14K | |
| 87506 | <1% | 325 | $14K | |
| 85652 | <1% | 5,077 | $12K | |
| 84165 | <1% | 1,259 | $12K | |
| 82533 | <1% | 950 | $11K | |
| 86431 | <1% | 2,148 | $11K | |
| 87449 | <1% | 1,320 | $11K | |
| 82785 | <1% | 679 | $10K | |
| 86147 | <1% | 265 | $10K | |
| 87324 | <1% | 1,205 | $10K | |
| 83615 | <1% | 1,877 | $10K | |
| 86146 | <1% | 249 | $9K | |
| 86376 | <1% | 745 | $9K | |
| 87205 | <1% | 2,207 | $9K | |
| 86901 | <1% | 3,722 | $9K | |
| 86790 | <1% | 821 | $9K | |
| 82378 | <1% | 624 | $8K | |
| 85730 | <1% | 1,521 | $8K | |
| 82310 | <1% | 2,819 | $8K | |
| 82040 | <1% | 3,520 | $8K | |
| 86900 | <1% | 3,721 | $8K | |
| 86304 | <1% | 665 | $8K | |
| 87209 | <1% | 519 | $7K | |
| 88142 | <1% | 514 | $7K | |
| 86308 | <1% | 1,246 | $7K | |
| 82977 | <1% | 1,171 | $7K | |
| 82947 | <1% | 1,994 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 17 | $6K |
| 86235 | <1% | 286 | $6K | |
| 84144 | <1% | 345 | $6K | |
| 85379 | <1% | 744 | $6K | |
| 83993 | <1% | 352 | $6K | |
| 80081 | <1% | 230 | $5K | |
| 85018 | <1% | 2,538 | $5K | |
| 85014 | <1% | 2,538 | $5K | |
| 83883 | <1% | 422 | $5K | |
| 87493 | <1% | 124 | $5K | |
| 86800 | <1% | 428 | $5K | |
| 81513 | <1% | 4,805 | $4K | |
| 88341 | <1% | 78 | $4K | |
| 87177 | <1% | 519 | $4K | |
| 80197 | <1% | 1,137 | $4K | |
| 86787 | <1% | 373 | $4K | |
| 83605 | <1% | 453 | $3K | |
| 87040 | <1% | 332 | $3K | |
| 84478 | <1% | 473 | $2K | |
| 86708 | <1% | 256 | $2K | |
| 86300 | <1% | 227 | $2K | |
| 82247 | <1% | 512 | $2K | |
| 84432 | <1% | 152 | $2K | |
| 86593 | <1% | 570 | $2K | |
| 82248 | <1% | 367 | $1K | |
| 84155 | <1% | 641 | $1K | |
| 85045 | <1% | 317 | $934.41 | |
| 85613 | <1% | 76 | $696.07 | |
| 80164 | <1% | 87 | $657.53 | |
| 86039 | <1% | 79 | $582.35 | |
| 86334 | <1% | 56 | $580.84 | |
| 82962 | <1% | 300 | $567.44 | |
| 80178 | <1% | 141 | $565.17 | |
| 86765 | <1% | 40 | $487.45 | |
| 82677 | <1% | 54 | $425.56 | |
| 86301 | <1% | 29 | $393.29 | |
| 86336 | <1% | 53 | $391.27 | |
| 89051 | <1% | 116 | $364.00 | |
| 82390 | <1% | 39 | $334.46 | |
| 83655 | <1% | 52 | $238.15 | |
| 80047 | <1% | 26 | $232.01 | |
| 87338 | <1% | 38 | $217.14 | |
| 80175 | <1% | 25 | $196.80 | |
| 88302 | <1% | 29 | $161.84 | |
| 89055 | <1% | 38 | $157.55 | |
| 87075 | <1% | 27 | $142.05 | |
| 80051 | <1% | 14 | $116.15 | |
| 85651 | <1% | 22 | $93.00 | |
| 87102 | <1% | 13 | $84.51 | |
| 84425 | <1% | 13 | $73.92 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 85 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAMSEIER, MICHAEL (REGIONAL PRESIDENT)
Parent organizationKAISER PERMANENTE
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.